Immunewalk Therapeutics
Manufacturing · New York, United States · 1-10 Employees
View Company Info for Free
Overview
Headquarters
1 Blue Hill Plz, Pearl River, New York, ...Website
www.immunewalk.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Mar
Apr
May
Jun
Jul
Aug
ZI Rank
1
1
1
1
1
1
About Immunewalk Therapeutics
ImmuneWalk Therapeutics is a clinical-stage biotechnology company dedicated to developing novel therapies for immune-inflammatory diseases. Central to their approach is the discovery of a new adhesion checkpoint that regulates the migration of specific immune cells into inflamed tissues. This innovative mechanism offers a differentiated approach compared to existing anti-inflammatory agents. Their lead candidate, IW-601, is an engineered monoclonal antibody that has demonstrated disease-modifying activity in preclinical models of multiple sclerosis, rheumatoid arthritis, inflammatory bowel disease, and metabolic dysfunction-associated steatohepatitis.Explore more
Immunewalk Therapeutics Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Immunewalk Therapeutics your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Check if Immunewalk Therapeutics has recently received funding, and reach out quickly before it becomes old news!
Product Launch: Get notified when Immunewalk Therapeutics launches new products
Immunewalk Therapeutics, which may be a good buyer, showed buying intent in Masked Content Topic
Congratulate Masked Content for being promoted to Masked Content at Immunewalk Therapeutics
Funding: Get notified immidiatlly once Immunewalk Therapeutics has new funding data
Check out if Immunewalk Therapeutics is spiking on competitors!
Click to see if Immunewalk Therapeutics had a recent Job posting/layoffs
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Website visits: Recent activity has been detected on your website
Earning: See what the market has to say on Immunewalk Therapeutics recently announced quarterly report
Recommended Actions
Reach out to Masked Content who joined Immunewalk Therapeutics as Masked Content
Find 3 more new buyers
Company Profile Activity
Activity Insights
Immunewalk Therapeutics is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Immunewalk Therapeutics is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Immunewalk Therapeutics.
Immunewalk Therapeutics financials insights
Gather financial insights about Immunewalk Therapeutics, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2025
Seed
$7M
Most Recent Scoops
Left Company
Executive Move
Executive Moves, Left Company
Event
Product Marketing, Events, Learning & Development, Software, Bioengineering, Pharmaceuticals, Public Health, Field /Outside Sales, Field Marketing, Healthcare Technology, Patient Experience
Funding
Funding
Funding
Immunewalk Therapeutics News & Media
ImmuneWalk Therapeutics Announces Positive Topline Phase 1 SAD Data for Immunology and Inflammation Drug Candidate IW-601
NEW YORK and PETACH TIKVAH, Israel, June 11, 2025 (GLOBE NEWSWIRE) -- ImmuneWalk Therapeutics, a clinical stage company focused on modulating immune and inflammatory disease by preventing myeloid cells (monocytes and neutrophils) from entering inflamed tissues, today announced the presentation of positive topline data from the single ascending dose (SAD) portion of the Phase 1 POINTGUARD study evaluating subcutaneously administered IW-601 at the EULAR 2025 conference in Barcelona. The dose-rangi
Read more news
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Immunewalk Therapeutics
Sign Up For FreeTo access detailed company insights
ImmuneWalk Therapeutics is a clinical-stage biotechnology company dedicated to developing novel therapies for immune-inflammatory diseases. Central to their approach is the discovery of a new adhesion checkpoint that regulates the migration of specific immune cells into inflamed tissues. This innovative mechanism offers a differentiated approach co... Read More
